August 27, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Grelan Pharmaceutical, Teijin Pharma to Jointly Market Lipid-lowering Agent in Japan
 

Tokyo, Apr 28, 2004 (JCN) - Grelan Pharmaceutical announced on April 26 that it has concluded a sales agreement with Teijin Pharma (TSE: 3401) for "Fenofibrate," a lipid-lowering agent manufactured by French Fournier Pharma.

Under this agreement, Grelan and Teijin will jointly promote and distribute a pulverized type (fine powder) of "Fenofibrate."

By Dale Hug Staff Writer

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Teijin Group News  
  Teijin Develops Advanced Outerwear Fabric  (June 16, 2014)
  Teijin DuPont Films Develops World-class Flame-retardant Film  (Apr 8, 2014)
  Teijin Frontier to Establish New Company in Myanmar  (Sept 9, 2013)
  Teijin's Technora Para-aramid Fiber to be used in Space Elevator Challenge  (Aug 6, 2013)
  Teijin's High-performance Polyester used for High-quality Bedding by ANA  (Aug 2, 2013)
  Teijin Develops Eco-friendly Wet-strong Printing Paper  (Mar 12, 2013)
  Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping  (Feb 21, 2013)
  Teijin Chemicals, SK Chemicals Form JV to Enter PPS Resin Business  (Feb 5, 2013)
  Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business  (Jan 22, 2013)
  Mitsubishi Outlander Uses Teijin's V-Lap Polyester Material  (Nov 28, 2012)


 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)